Mutations that cause esophageal adenocarcinoma (OAC) have been mapped in unprecedented detail -- unveiling that more than half could be targeted by drugs currently in trials for other cancer types.
from Breast Cancer News -- ScienceDaily http://bit.ly/2UAhEv0
0 comments:
Post a Comment